TrialRadiation oncology (London, England)2023

Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9).

Dashan Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.